2026 NPPES data Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist NPI 1952034894 PHARMD
Verify on CMS →

Chase Anglin, PHARMD

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Grand Bay, Alabama.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 14,139 in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
94
Medicare Part D claims · 85 beneficiaries · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist avg: 231
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Chase Anglin, PHARMD filed 94 Medicare Part D claims in 2024 as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Grand Bay, Alabama, prescribing 0% generic.

94
Part D claims, 2024
0%
generic prescribing
≥0th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Chase Anglin, PHARMD

Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1952034894), first enumerated 07/07/2022.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 94 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1952034894 · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

NPI-10 · ENUM-RECENT · TAX-MID · RX-TRACE · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1952034894
  • ENUM-RECENT 2022
  • TAX-MID 14K Pharmacist Clinician
  • RX-TRACE 94
  • BOOK-THIN 139 in Alabama
  • PHOTO-ENUM Carson Jones · 2022

Chase Anglin, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

94 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

What does the federal data show about Chase Anglin, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 07/07/2022

NPI 1952034894

Primary specialty

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Mid-sized

14,139 US NPIs in this specialty

Medicare Part D claims

94 59% vs specialty avg

2024 prescription claims

Specialty avg: 231

Specialty distribution in Alabama

How Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist compares to other specialties among Alabama providers

Alabama providers
Student in an Organized Heal…8.4%Pharmacist6.6%Family Nurse Practitioner5.9%Behavior Technician4.7%Physical Therapist4.2%Mental Health Counselor3.4%Pharmacist Clinician (PhC)/ …0.2%
Largest specialties in Alabama (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

12550 US HIGHWAY 90
Grand Bay, AL 36541

Provider Details

NPI 1952034894
Specialty Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Credentials PHARMD
Gender Male
NPI Issued 07/07/2022

Brand vs generic prescribing mix · Brand-heavy

Chase Anglin, PHARMD - brand share 100.0%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist average

100% brand-name claims vs 0% generic, on 94 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

94
Total Claims
$20K
Total Drug Cost
85
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
94
Total Day Supply
94
Brand vs Generic
100% brand / 0% generic
Brand Drug Cost
$20K
Generic Drug Cost
$0

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
1.22
Gender Split
61% female / 39% male
Age Distribution
<65: 11, 65-74: 34, 75-84: 27, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

Drug Claims
Shingrix
Varicella-Zoster Ge/As01b/Pf
45
Arexvy
Rsvpref3 Antigen/As01e/Pf
39

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Overview

How Chase Anglin, PHARMD fits within the Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist landscape nationally.

14,139
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in US
55
States with Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
231
Avg Claims per Provider

Chase Anglin, PHARMD's 94 claims are below the specialty average of 231.

Nationwide Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist peers with similar MIPS or enrollment year

Two federal-record peer sets for Anglin, both outside Alabama so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2022)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as Anglin.

One of 139 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers enrolled in Alabama, 5 are shown here.

Compare Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is Chase Anglin, PHARMD's specialty?
Chase Anglin, PHARMD specializes in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist and practices in Grand Bay, Alabama. Credentials: PHARMD.
How much does Chase Anglin, PHARMD prescribe under Medicare Part D?
In 2024, Chase Anglin, PHARMD wrote 94 Medicare Part D claims totaling $20K in drug costs for 85 beneficiaries.
Where is Chase Anglin, PHARMD located?
Chase Anglin, PHARMD is located at 12550 US HIGHWAY 90, Grand Bay, AL, 36541. Phone: (251) 865-1429.
What is Chase Anglin, PHARMD's NPI number?
Chase Anglin, PHARMD's National Provider Identifier (NPI) is 1952034894, issued on 07/07/2022.
Does Chase Anglin, PHARMD prescribe more brand-name or generic drugs?
Chase Anglin, PHARMD's prescribing is 100% brand-name and 0% generic drugs by claim count, with $20K in brand drug costs.
How many Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers are there in the US?
There are 14,139 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers across 55 states in the US. The average Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider writes 231 Medicare Part D claims per year.
What drugs does Chase Anglin, PHARMD prescribe most often?
Based on 2024 Medicare Part D data, Chase Anglin, PHARMD's most frequently prescribed drugs include Shingrix, Arexvy. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Chase Anglin, PHARMD accept Medicare?
Chase Anglin, PHARMD appears in CMS Medicare data with 94 Part D claims and 85 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Chase Anglin, PHARMD's credentials?
Chase Anglin, PHARMD's NPI is 1952034894 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.